Standout Papers

Recent development of gol... 2022 2026 2023 2024 2022 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. Recent development of gold(i) and gold(iii) complexes as therapeutic agents for cancer diseases
    2022 173 citations Yunlong Lu, Xiaoyan Ma et al. Chemical Society Reviews profile →

Immediate Impact

1 by Nobel laureates 67 hit
Sub-graph 1 of 25

Citing Papers

Selenium in cancer management: exploring the therapeutic potential
2025 Hit
Thirty years of NRF2: advances and therapeutic challenges
2025 Hit
2 intermediate papers

Works of Qiuyue Lu being referenced

Mecheliolide elicits ROS-mediated ERS driven immunogenic cell death in hepatocellular carcinoma
2022
Recent development of gold(i) and gold(iii) complexes as therapeutic agents for cancer diseases
2022 Hit

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Qiuyue Lu 127 123 99 66 41 8 326
Rocío Cejudo-Marín 75 0.6× 42 0.3× 194 2.0× 21 0.3× 24 0.6× 12 327
Mario Marchesi 129 1.0× 25 0.2× 91 0.9× 42 0.6× 37 0.9× 13 340
Kai-Di Zhao 109 0.9× 52 0.4× 131 1.3× 41 0.6× 14 0.3× 11 334
Zhenfan Wen 154 1.2× 134 1.1× 94 0.9× 42 0.6× 34 0.8× 10 350
Paul C. Collins 36 0.3× 130 1.1× 110 1.1× 39 0.6× 81 2.0× 12 353
Jennifer A. Irwin 56 0.4× 39 0.3× 85 0.9× 31 0.5× 27 0.7× 11 357
Lucienne Lagopoulos 148 1.2× 136 1.1× 111 1.1× 47 0.7× 83 2.0× 6 360
Karina Alexandre Barros Nogueira 55 0.4× 28 0.2× 105 1.1× 103 1.6× 81 2.0× 10 365
Bing‐Bing Liang 123 1.0× 122 1.0× 108 1.1× 58 0.9× 62 1.5× 16 330
Linxiang Cai 198 1.6× 137 1.1× 111 1.1× 48 0.7× 47 1.1× 14 363

All Works

Loading papers...

Rankless by CCL
2026